What's driving Animal Healthcare Market ; Eminent Players - Zoetis, Merck, Elanco, Bayer, Boehringer Ingelheim, Virbac, Ceva Sante Animale, Phirbo Animal Health, Vetoquinol

Animal healthcare providers on the other hand are levelling up the game with the implementation of various strategies. Manufacturers are focused on developing new products to increase the acceptance of Animal Healthcare, thus expecting to increase their respective market shares.

The companies are focusing on outsourcing the manufacturing of animal healthcare products in order to reduce their manufacturing costs and also compete in the market with reduced prices. Some of the leading companies operating in the global animal healthcare market are Bayer AG, Boehringer Ingelheim GmbH, Virbac S.A., Zoetis, Inc., Hester Biosciences Ltd., and Intas Pharmaceuticals Ltd.

Request Sample of This Report @ https://www.persistencemarketresearch.com/samples/2882

According to a report published by Persistence Market Research (PMR), the global animal healthcare market is expected to witness a CAGR of 4.8% from 2017 to 2025. In 2017, the market was worth US$ 30,744.2 Mn and is estimated to rise to a valuation of US$ 44,847.2 Mn by the end of 2025.

A significant increase in animal farming has led to a rise in demand for animal health services for improvement of food safety systems and veterinary public health in order to safeguard human health. The adoption of animal healthcare services is highly dependent on the fiscal, political, and institutional factors of the country. In order to increase the adoption of animal health services, governments directly take part by increasing awareness among the general population regarding animal diseases and privatization of animal healthcare services.

One such scheme in Europe is Livestock Insurance, which was implemented to increase the effectiveness and efficiency of animal healthcare systems. Another case that can be considered is of the U.K. government compen-sating direct loses incurring owing to the outbreaks from the EU compensation schemes and the U.K. national budget.

Animals are more susceptible to a wide range of contagious diseases such as peste des petits ruminants, foot-and-mouth disease, bovine pleuropneumonia, Newcastle disease, classical and African swine fever, and influenza (particularly equine and avian influenza), among others, through direct or indirect contact. Peste des petits rumi-nants (PPR) or goat plague is highly contagious disease that generally affects small ruminants. According to the Food and Agricultural Organization, PPR virus can infect up to 90% of small ruminant population and can even result in deaths of 30–70% of the animal population.

Request For Methodology @ https://www.persistencemarketresearch.com/methodology/2882

Mounting concerns over the provision of illicit drugs in developing and under-developed countries are expected to restrain the growth of animal healthcare market. Illegal drugs are unregistered and falsified, counterfeit products, and unapproved parallel imports. This also includes illegal autogenous vaccines and compounded pharmaceuticals.

These products are not manufactured or used appropriately in accordance with regulations. The risk of illegal medicines is not only due to lack of efficacy and safety of animals but they also affect the sale of approved drugs. Use of counterfeit medicines for animal health, which are usually cheap and of low quality, has a strong negative impact on the branded drugs market. Trend of counterfeit medicines is more commonly seen in under-developed and developing countries and as a result, the demand of the approved medicines witness a decline.

Table of Content

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations

1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy

3. Animal Healthcare Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. Market Background
4.1. Market Dynamics
4.1.1. Drivers

4.1.2. Restraints
4.1.3. Trends
4.1.4. Opportunity Analysis
4.2. Regulatory Scenario

5. Key Inclusions
5.1. Key Distributor List, By Region
5.2. Top Veterinary Drugs/Brands
5.2.1. Companion Animals
5.2.2. Farm Animals
5.3. Porter’s Five Force Analysis

6. North America Animal Healthcare Market Analysis 2012–2016 and Forecast 2017–2025
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
6.2.1. U.S.

6.2.2. Canada
6.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
6.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2012–2016
6.4.1. Anti-Infective Agents
6.4.1.1. Antibiotics & Antimicrobials

6.4.1.2. Antifungal
6.4.1.3. Antiviral
6.4.2. Anti-inflammatory Agents & Analgesics
6.4.3. Parasiticides

6.4.3.1. Endo-parasiticides
6.4.3.2. Ecto-Parasiticides
6.4.3.3. Endectocides
6.4.4. Vaccines
6.4.5. Hormones and Substitutes

6.4.6. Nutritional Products
6.4.7. Others
6.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
6.6. Historical Market Size (US$ Mn) Trend Analysis By Animal Type, 2012–2016
6.6.1. Companion Animal
6.6.1.1. Cats

6.6.1.2. Dogs
6.6.1.3. Horse
6.6.2. Farm Animals
6.6.2.1. Ruminants
6.6.2.2. Swine

6.6.2.3. Poultry
6.7. Market Size (US$ Mn) Forecast By Animal Type, 2017–2025
6.8. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2012–2016
6.8.1. Oral
6.8.1.1. Tablets/Capsules
6.8.1.2. Liquids

6.8.1.3. Powders / premix
6.8.1.4. Others (sprinkles)
6.8.2. Parenteral
6.8.2.1. Liquids

6.8.2.2. Powder for Injection
6.8.3. Topical
6.8.3.1. Solutions (spot-on, pour-on)
6.8.3.2. Creams & Ointments
6.8.3.3. Intramammary preparations

6.8.3.4. Others (powders, etc.)
6.8.4. Others
6.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
6.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
6.10.1. Veterinary Hospitals

6.10.2. Veterinary Clinics
6.10.3. Pharmacies and Drug Stores
6.10.4. Others
6.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
6.12. Market Attractiveness Analysis

6.12.1. By Country
6.12.2. By Drug Type
6.12.3. By Animal Type
6.12.4. By Route of Administration
6.12.5. By Distribution Channel
6.13. Key Market Participants – Intensity Mapping
6.14. Drivers and Restraints – Impact Analysis

Buy Now @ https://www.persistencemarketresearch.com/checkout/2882

ABOUT US:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.